More questions are being raised about SPRINT, the enormous NIH-funded blood pressure lowering trial. Two recent developments will likely add more obstacles to the already difficult task of applying the results of the trial in the real world. Even before the full results of the trial were first made public the NIH and the SPRINT…
Clinical Trialists Dig In And Vote For Status Quo
–Doctors who got famous for doing clinical trials resist changes to the clinical trial system. It should probably come as no surprise that hundreds of clinical trial investigators whose positions and livelihoods depend largely on the existing clinical trial system have expressed great reluctance and annoyance at a proposal that could radically shake up that system. As…
Top Clinical Investigators Seek To Dampen Impact Of Data Sharing
Despite earlier concerns by its editors about “data parasites,” the New England Journal of Medicine has now published 4 articles offering support in some form for data sharing. But two of the articles— written by many of the most prominent clinical trial researchers in the United States and Canada— express grave concerns about data sharing…
NEJM Editor Flip Flops On Data Sharing After Social Media Firestorm
After a firestorm of criticism on social media over his editorial comments, Jeffrey Drazen, the editor-in-chief of the New England Journal of Medicine, is trying to quiet a growing controversy by modifying his position regarding shared data. The firestorm was ignited by an editorial on data sharing in last week’s NEJM. Although highly supportive of…
Editors Deliver Major Victory To Open Data Movement
The open data movement has gained its biggest victory yet. In an editorial published simultaneously in 14 major medical journals today, The International Committee of Medical Journal Editors (ICMJE) delivered a full-throated endorsement, in both actions as well as words, of data sharing by clinical researchers. Here is the core of the ICMJE proposal: As…
Recent Comments